Literature DB >> 11053208

Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

M K Mundey1, A Ali, R Mason, V G Wilson.   

Abstract

We have assessed the potential of several mu-opioid receptor antagonists to elicit a response in the guinea-pig isolated ileum in the presence of, and following overnight exposure to, morphine. Naloxone, D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH(2) (CTOP), (-)-5, 9alpha-diethyl-2-(3-furyl-methyl)-2'-hydroxy-6,7-benzomorphan (MR2266), but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2) (CTAP), produced a transient inhibition of electrically-evoked contractions of the guinea-pig ileum. The effect of 1 microM CTOP, but not that to MR2266, was inhibited by 1 microM somatostatin. Naloxone (0.3 microM), CTOP (3 microM), CTAP (3 microM) and MR2266 (0.3 microM) antagonized the inhibitory effect of morphine on electrically-evoked contractions of the guinea-pig to a similar degree and, following 60 min exposure to morphine, produced non-sustained contractions. The response to 3 microM CTOP was significantly smaller than that to 3 microM CTAP. None of the antagonists produced a response in the absence of morphine. Following overnight exposure of the ileum to 0.3 microM morphine (4 degrees C), and repeated washing to remove the agonist, all four antagonists elicited non-sustained contractions. However, the responses to 3 microM CTOP and 0.3 microM MR2266 were significantly smaller than those elicited by 0.3 microM naloxone and 3 microM CTAP. Somatostatin (1 microM) significantly reduced naloxone-induced contractions, but not those to CTAP. While all four mu-opioid antagonists elicited contractions in the presence of, and following prolonged exposure to, morphine, differences between them were noted which may be a consequence of non-opioid actions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053208      PMCID: PMC1572416          DOI: 10.1038/sj.bjp.0703659

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Molecular mechanisms of drug addiction.

Authors:  E J Nestler
Journal:  J Neurosci       Date:  1992-07       Impact factor: 6.167

2.  No relation of plasma morphine level to the severity of naloxone-induced withdrawal in acute morphine-dependent rats.

Authors:  S Kishioka; N Inoue; S Nishida; Y Fukunaga; H Yamamoto
Journal:  Jpn J Pharmacol       Date:  1995-11

3.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

Authors:  G Milligan; R A Bond; M Lee
Journal:  Trends Pharmacol Sci       Date:  1995-01       Impact factor: 14.819

4.  Evidence for functional dissociation of dependence and tolerance in guinea-pig isolated ileal segments following 20 hour exposure to morphine in vitro.

Authors:  C David; N Davis; R Mason; V G Wilson
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

5.  Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists.

Authors:  R Maldonado; S Negus; G F Koob
Journal:  Neuropharmacology       Date:  1992-12       Impact factor: 5.250

6.  Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.

Authors:  K M Standifer; J Cheng; A I Brooks; C P Honrado; W Su; L M Visconti; J L Biedler; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

7.  Further evidence from functional studies for somatostatin receptor heterogeneity in guinea-pig isolated ileum, vas deferens and right atrium.

Authors:  W Feniuk; J Dimech; E M Jarvie; P P Humphrey
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

8.  Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.

Authors:  T Avidor-Reiss; M Bayewitch; R Levy; N Matus-Leibovitch; I Nevo; Z Vogel
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

9.  Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.

Authors:  Z Wang; E J Bilsky; F Porreca; W Sadée
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

10.  Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.

Authors:  E J Bilsky; R N Bernstein; Z Wang; W Sadée; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1996-04       Impact factor: 4.030

View more
  7 in total

1.  In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay.

Authors:  E A Walker
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

2.  Antinociceptive activity and toxicology of the lectin from Canavalia boliviana seeds in mice.

Authors:  Jozi Godoy Figueiredo; Flávio da Silveira Bitencourt; Ingrid Gonçalves Beserra; Cícero Silvano Teixeira; Patrícia Bastos Luz; Eduardo Henrique Salviano Bezerra; Mário Rogério Lima Mota; Ana Maria Sampaio Assreuy; Fernando de Queiroz Cunha; Benildo Sousa Cavada; Nylane Maria Nunes de Alencar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-25       Impact factor: 3.000

3.  Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.

Authors:  Ellen A Walker; Steven N Sterious
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Citronellol, a monoterpene alcohol, reduces nociceptive and inflammatory activities in rodents.

Authors:  Renan G Brito; Adriana G Guimarães; Jullyana S S Quintans; Marcio R V Santos; Damião P De Sousa; Daniel Badaue-Passos; Waldecy de Lucca; Fabíola A Brito; Emiliano O Barreto; Aldeídia P Oliveira; Lucindo J Quintans
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

5.  Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.

Authors:  M F Divin; F A Bradbury; F I Carroll; J R Traynor
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

6.  The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.

Authors:  D T Beattie; M Cheruvu; N Mai; M O'Keefe; S Johnson-Rabidoux; C Peterson; E Kaufman; R Vickery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-06       Impact factor: 3.000

7.  Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation.

Authors:  R J Schepers; Janet Lynn Mahoney; Brenda Jean Gehrke; Toni Shaun Shippenberg
Journal:  Pain       Date:  2008-03-19       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.